famotidine has been researched along with Hepatitis in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Hepatitis: INFLAMMATION of the LIVER.
Excerpt | Relevance | Reference |
---|---|---|
"Famotidine clearance was reduced only in patients with decompensated cirrhosis, probably because of concomitant renal impairment." | 5.28 | Effects of hepatic disease on the pharmacokinetics of famotidine and effects of famotidine on hepatic hemodynamics and peptic ulcer. ( Ohnishi, K, 1990) |
"The pharmacokinetics of famotidine were studied after the administration of a single intravenous dose of 20-mg to seven normal volunteers, six patients with chronic hepatitis, 14 patients with compensated cirrhosis, and seven patients with decompensated cirrhosis." | 3.68 | Pharmacokinetics of famotidine after intravenous administration in liver disease. ( Ohnishi, K, 1991) |
"Famotidine clearance was reduced only in patients with decompensated cirrhosis, probably because of concomitant renal impairment." | 1.28 | Effects of hepatic disease on the pharmacokinetics of famotidine and effects of famotidine on hepatic hemodynamics and peptic ulcer. ( Ohnishi, K, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ohnishi, K | 2 |
2 other studies available for famotidine and Hepatitis
Article | Year |
---|---|
Pharmacokinetics of famotidine after intravenous administration in liver disease.
Topics: Adult; Aged; Chronic Disease; Famotidine; Female; Half-Life; Hepatitis; Humans; Infusions, Intraveno | 1991 |
Effects of hepatic disease on the pharmacokinetics of famotidine and effects of famotidine on hepatic hemodynamics and peptic ulcer.
Topics: Adult; Chronic Disease; Famotidine; Female; Hepatitis; Humans; Liver Circulation; Liver Cirrhosis; L | 1990 |